The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 07, 2012
Filed:
Mar. 28, 2008
Günther Metz, Lörrach, DE;
Holger Deppe, Füllinsdorf, CH;
Ulrich Abel, Heidelberg, DE;
Achim Feurer, Auggen, DE;
Inge Ott, Ketsch, DE;
Sonja Nordhoff, Arlesheim, CH;
Michael Soeberdt, Rheinfelden, DE;
Barbara Hoffmann-enger, Therwil, CH;
Philipp Weyermann, Sissach, CH;
Hervé Siendt, Ranspach-le-Haut, FR;
Christian Rummey, Basel, CH;
Miroslav Terinek, Bubendorf, CH;
Marco Henneböhle, Rheinfelden, DE;
Holger Herzner, Rümmingen, DE;
Cesare Mondadori, Reinach, CH;
Günther Metz, Lörrach, DE;
Holger Deppe, Füllinsdorf, CH;
Ulrich Abel, Heidelberg, DE;
Achim Feurer, Auggen, DE;
Inge Ott, Ketsch, DE;
Sonja Nordhoff, Arlesheim, CH;
Michael Soeberdt, Rheinfelden, DE;
Barbara Hoffmann-Enger, Therwil, CH;
Philipp Weyermann, Sissach, CH;
Hervé Siendt, Ranspach-le-Haut, FR;
Christian Rummey, Basel, CH;
Miroslav Terinek, Bubendorf, CH;
Marco Henneböhle, Rheinfelden, DE;
Holger Herzner, Rümmingen, DE;
Cesare Mondadori, Reinach, CH;
Santhera Pharmaceuticals (Schweiz) AG, Liestal, CH;
Abstract
The present invention relates to substituted imidazopyridine derivatives as melanocortin-4 receptor (MC-4R) modulators, in particular as melanocortin-4 receptor antagonists. The antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, amytrophic lateral sclerosis (ALS), anxiety and depression.